These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1176 related items for PubMed ID: 32525936

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
    Chatzistamatiou K, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, Pasentsis K, Skenderi A, Stamatopoulos K, Agorastos T.
    Gynecol Oncol; 2021 Sep; 162(3):560-568. PubMed ID: 34210517
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ.
    Cochrane Database Syst Rev; 2013 Mar 28; 2013(3):CD008054. PubMed ID: 23543559
    [Abstract] [Full Text] [Related]

  • 6. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X, Liao G, Sun L, Zhang Y, Chen W, Qiao YL.
    Cancer Prev Res (Phila); 2020 Feb 28; 13(2):163-172. PubMed ID: 31871224
    [Abstract] [Full Text] [Related]

  • 7. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M, Oštrbenk A, Seme K, Šterbenc A, Jančar N, Vrtačnik Bokal E.
    J Clin Virol; 2016 Mar 28; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
    Song F, Belinson JL, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    Gynecol Oncol; 2021 Aug 28; 162(2):322-330. PubMed ID: 34059349
    [Abstract] [Full Text] [Related]

  • 9. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
    Hernández-López R, Lorincz AT, Torres-Ibarra L, Reuter C, Scibior-Bentkowska D, Warman R, Nedjai B, Mendiola-Pastrana I, León-Maldonado L, Rivera-Paredez B, Ramírez-Palacios P, Lazcano-Ponce E, Cuzick J, Salmerón J, FRIDA Study Group.
    Clin Epigenetics; 2019 Oct 12; 11(1):140. PubMed ID: 31606044
    [Abstract] [Full Text] [Related]

  • 10. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
    Ebisch RM, de Kuyper-de Ridder GM, Bosgraaf RP, Massuger LF, IntHout J, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Bulten J, Siebers AG, Bekkers RL, Melchers WJ.
    Int J Cancer; 2016 Aug 01; 139(3):691-9. PubMed ID: 26991464
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K, Moysiadis T, Angelis E, Kaufmann A, Skenderi A, Jansen-Duerr P, Lekka I, Kilintzis V, Angelidou S, Katsiki E, Hagemann I, Tsertanidou A, Koch I, Boecher O, Soutschek E, Maglaveras N, Agorastos T.
    Arch Gynecol Obstet; 2017 May 01; 295(5):1247-1257. PubMed ID: 28337594
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
    Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G, New Technologies for Cervical Cancer Screening Working Group.
    Int J Cancer; 2020 Oct 01; 147(7):1864-1873. PubMed ID: 32170961
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q, Zhao M, Cao D, Wei X, Wang L, Li Y, Yang T, Zhao J, Pei M, Jia H, Cao S, Quan S, Yang X.
    J Med Virol; 2018 Jan 01; 90(1):165-171. PubMed ID: 28710863
    [Abstract] [Full Text] [Related]

  • 15. Primary HPV testing verification: A retrospective ad-hoc analysis of screening algorithms on women doubly tested for cytology and HPV.
    Tracht J, Wrenn A, Eltoum IE.
    Diagn Cytopathol; 2017 Jul 01; 45(7):580-586. PubMed ID: 28436211
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.
    Hanley SJB, Fujita H, Aoyama-Kikawa S, Kasamo M, Torigoe T, Matsuno Y, Noriaki S, COMPACT study group.
    J Gynecol Oncol; 2021 Nov 23; 32(6):e86. PubMed ID: 34708593
    [Abstract] [Full Text] [Related]

  • 18. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
    Verhoef VM, Heideman DA, van Kemenade FJ, Rozendaal L, Bosgraaf RP, Hesselink AT, Bekkers RL, Massuger LF, Steenbergen RD, Snijders PJ, Berkhof J, Meijer CJ.
    Gynecol Oncol; 2014 Oct 23; 135(1):58-63. PubMed ID: 25111387
    [Abstract] [Full Text] [Related]

  • 19. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, Brotherton J, Gertig D, Jennett CJ, Farnsworth A, Tan J, Wrede CD, Castle PE, Saville M.
    PLoS Med; 2017 Sep 23; 14(9):e1002388. PubMed ID: 28926579
    [Abstract] [Full Text] [Related]

  • 20. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China.
    Song F, Yan P, Huang X, Wang C, Qu X, Du H, Wu R.
    BMC Infect Dis; 2021 Apr 30; 21(1):400. PubMed ID: 33931022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.